| Date | Form | Description | Docs | XBRL | Pages |
| 08/27/13 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 08/27/13 | DEF 14A | Definitive proxy statements |
|
36 | |
| 08/12/13 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
37 | |
| 07/16/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/16/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/16/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/16/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/16/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/19/13 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
56 | |
| 06/19/13 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
124 |
Latest News & Events
Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
Read More...Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s
Read More...Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025
Read More...